Page last updated: 2024-11-04

vorinostat and Lupus Nephritis

vorinostat has been researched along with Lupus Nephritis in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Lupus Nephritis: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, N1
Zhao, D1
Kirschbaum, M1
Zhang, C1
Lin, CL1
Todorov, I1
Kandeel, F1
Forman, S1
Zeng, D1

Other Studies

1 other study available for vorinostat and Lupus Nephritis

ArticleYear
HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Mar-25, Volume: 105, Issue:12

    Topics: Aging; Animals; Apoptosis; CD3 Complex; Cell Proliferation; Chimerism; Cytokines; Dose-Response Rela

2008